Variant report
Variant | nsv970704 |
---|---|
Chromosome Location | chr6:140672576-140676024 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374602557 | chr6:140672597-140672598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576787587 | chr6:140672611-140672612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186930606 | chr6:140672617-140672618 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546171401 | chr6:140672631-140672632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs477498 | chr6:140672641-140672642 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs191998951 | chr6:140672681-140672682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12211063 | chr6:140672685-140672686 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534870042 | chr6:140672697-140672698 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143357223 | chr6:140672763-140672764 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569064990 | chr6:140672846-140672847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372134517 | chr6:140672858-140672859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539708675 | chr6:140672946-140672947 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557933066 | chr6:140672999-140673000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557713047 | chr6:140673031-140673032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542174096 | chr6:140673084-140673085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9389797 | chr6:140673086-140673087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111247684 | chr6:140673312-140673313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548489240 | chr6:140673314-140673315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562235514 | chr6:140673326-140673327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571399959 | chr6:140673330-140673331 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531127427 | chr6:140673377-140673378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs17069935 | chr6:140673413-140673414 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs555910180 | chr6:140673430-140673431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149957947 | chr6:140673433-140673434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185371563 | chr6:140673458-140673459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189978302 | chr6:140673497-140673498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553886977 | chr6:140673549-140673550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569755980 | chr6:140673564-140673565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533503505 | chr6:140673597-140673598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545663164 | chr6:140673620-140673621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs560558585 | chr6:140673640-140673641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144871414 | chr6:140673647-140673648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35336300 | chr6:140673665-140673666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568450556 | chr6:140673675-140673676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182188681 | chr6:140673676-140673677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370189415 | chr6:140673685-140673686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534216912 | chr6:140673704-140673705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532153583 | chr6:140673733-140673734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187336850 | chr6:140673761-140673762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547714593 | chr6:140673816-140673817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375208947 | chr6:140673831-140673832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550200838 | chr6:140673868-140673869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112876682 | chr6:140673877-140673878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs568830451 | chr6:140673903-140673904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190198740 | chr6:140673925-140673926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183457405 | chr6:140673951-140673952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149030642 | chr6:140673969-140673970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533996877 | chr6:140673971-140673972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555563334 | chr6:140673997-140673998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188467425 | chr6:140674004-140674005 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:140668400-140674400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr6:140669000-140676400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr6:140670600-140672800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:140671600-140672800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr6:140671800-140672600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr6:140672200-140672600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr6:140672200-140672800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr6:140672400-140672800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr6:140672400-140673400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr6:140672600-140674400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr6:140672800-140673800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
12 | chr6:140674000-140674200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr6:140674200-140674600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr6:140674400-140674600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr6:140674400-140675200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
16 | chr6:140675200-140683000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |